blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3230738

EP3230738 - TEST APPARATUS FOR ST2 CARDIAC BIOMARKER [Right-click to bookmark this link]
Former [2017/42]TEST APPARATUS AND METHODS FOR ST2 CARDIAC BIOMARKER
[2019/23]
StatusNo opposition filed within time limit
Status updated on  25.09.2020
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  18.10.2019
FormerGrant of patent is intended
Status updated on  03.06.2019
FormerRequest for examination was made
Status updated on  15.09.2017
FormerThe international publication has been made
Status updated on  06.07.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Critical Care Diagnostics, Inc.
3030 Bunker Hill Street
Suite 117A
San Diego, CA 92109 / US
[2017/42]
Inventor(s)01 / SNIDER, James V.
1167 Hornblend Street
San Diego, California 92109 / US
02 / BENDER, Jillian Elizabeth
3103 Avenida Olmeda
Carlsbad, California 92009 / US
03 / KUO, Shrin P.
3088 Corte Trabuco
Carlsbad, California 92009 / US
04 / CHUNG, Roy A.
7567 Circulo Sequoia
Carlsbad, California 92009 / US
 [2017/42]
Representative(s)Williams, Gareth Owen
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[2017/42]
Application number, filing date15866534.911.12.2015
[2017/42]
WO2015US65176
Priority number, dateUS20141456693811.12.2014         Original published format: US201414566938
US20141456695511.12.2014         Original published format: US201414566955
[2017/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016094761
Date:16.06.2016
Language:EN
[2016/24]
Type: A2 Application without search report 
No.:EP3230738
Date:18.10.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2016 takes the place of the publication of the European patent application.
[2017/42]
Type: B1 Patent specification 
No.:EP3230738
Date:20.11.2019
Language:EN
[2019/47]
Search report(s)International search report - published on:US25.08.2016
(Supplementary) European search report - dispatched on:EP04.07.2018
ClassificationIPC:G01N33/558, B01L3/00, G01N33/68
[2018/31]
CPC:
G01N33/6893 (EP); G01N33/54388 (US); B01L3/5023 (EP);
B01L3/508 (EP); G01N33/543 (RU); G01N33/558 (EP,RU);
B01L2200/026 (EP); B01L2300/0636 (EP); B01L2300/0825 (EP);
B01L2400/0406 (EP); G01N2800/32 (EP) (-)
Former IPC [2018/20]G01N33/558, B01L3/00
Former IPC [2017/42]G01N33/53
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/42]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:TESTVORRICHTUNG FÜR ST2-HERZBIOMARKER[2019/23]
English:TEST APPARATUS FOR ST2 CARDIAC BIOMARKER[2019/23]
French:APPAREIL DE TEST POUR BIOMARQUEUR CARDIAQUE ST2[2019/23]
Former [2017/42]TESTVORRICHTUNG UND VERFAHREN FÜR ST2-HERZBIOMARKER
Former [2017/42]TEST APPARATUS AND METHODS FOR ST2 CARDIAC BIOMARKER
Former [2017/42]APPAREIL DE TEST ET PROCÉDÉS POUR BIOMARQUEUR CARDIAQUE ST2
Entry into regional phase05.07.2017National basic fee paid 
05.07.2017Search fee paid 
05.07.2017Designation fee(s) paid 
05.07.2017Examination fee paid 
Examination procedure05.07.2017Examination requested  [2017/42]
05.07.2017Date on which the examining division has become responsible
25.01.2019Amendment by applicant (claims and/or description)
04.06.2019Communication of intention to grant the patent
11.10.2019Fee for grant paid
11.10.2019Fee for publishing/printing paid
11.10.2019Receipt of the translation of the claim(s)
Opposition(s)21.08.2020No opposition filed within time limit [2020/44]
Fees paidRenewal fee
27.12.2017Renewal fee patent year 03
31.12.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.12.2015
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MK20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
[2022/32]
Former [2022/27]HU11.12.2015
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2021/34]HU11.12.2015
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2021/33]HU11.12.2015
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2021/26]AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/51]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE11.12.2019
LU11.12.2019
CH31.12.2019
LI31.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/46]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
IE11.12.2019
LU11.12.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/39]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/37]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/36]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/35]AL20.11.2019
CZ20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/32]AL20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/26]FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/24]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/23]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
Former [2020/22]FI20.11.2019
LT20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
Former [2020/21]NO20.02.2020
Documents cited:Search[A]EP1033575  (BAYER AG [US]) [A] 1-7,17 * the whole document, in particular figure 3; paragraph [0014] *;
 [A]EP1186889  (NISSUI PHARM CO LTD [JP]) [A] 1-7,17 * the whole document, in particular figures 1-3; paragraph [0024] *;
 [A]US2002146346  (KONECKE JEFFERY A [US]) [A] 1-7,17 * the whole document, in particular figure 6A; paragraphs [0065], [0066] *;
 [A]US6867051  (ANDERSON EMORY V [US], et al) [A] 1-7,17 * the whole document, in particular figures 3-5; column 37, lines 21-42 *;
 [A]US2007020768  (RUNDSTROM GERD [SE], et al) [A] 1-7,17 * the whole document, in particular figure 4; paragraph [0046] *;
 [A]US2009286692  (WAINWRIGHT NORMAN R [US], et al) [A] 1-7,17 * the whole document, in particular figure 5; paragraphs [0070], [0071] *;
 [A]US2012282634  (HUGHES GARY [US], et al) [A] 1-7,17 * the whole document, in particular figures 1, 2; paragraphs [0034]-[0036] *;
 [XI]CN102830234  (HANGZHOU HUADESEN BIOTECHNOLOGY CO LTD) [X] 8-13,16 * the whole document *[I] 14,15;
 [XI]CN203502418U  (SHIJIAZHUANG HUANZHONG BIOLOG SCIENCE & TECHNOLOGY CO LTD) [X] 8-10,13,16 * the whole document * [I] 11,12,14,15
International search[Y]US2009311805  (BERGMAN DAVID [SE], et al) [Y] 14-21, 35-41 * entire document *;
 [Y]US2011256635  (SNIDER JAMES V [US]) [Y] 10, 11, 31, 32 * entire document *;
 [XY]CN102830234  (HANGZHOU HUADESEN BIOTECHNOLOGY CO LTD) [X] 1-9, 12, 13, 22-30, 33, 34 * entire document; see machine translation * [Y] 10, 11, 31, 32;
 [Y]CN203502418U  (SHIJIAZHUANG HUANZHONG BIOLOG SCIENCE & TECHNOLOGY CO LTD) [Y] 20, 21 * entire document; see machine translation *;
 [Y]WO2014070935  (ASTUTE MEDICAL INC [US]) [Y] 14-19, 35-41 * entire document *;
 [A]CN203759015U  (CHENGDU LINGYU BIOTECH CO LTD) [A] 1-41* entire document; see machine translation *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.